A Randomized, Double-blind, Placebo-controlled, Mono-center Study to Evaluate the Effects of Mepolizumab on Airway Physiology in Patients With Eosinophilic Asthma: the MEMORY Study
Phase of Trial: Phase III
Latest Information Update: 17 Jul 2017
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms MEMORY
- 10 Jun 2017 Biomarkers information updated
- 04 Jun 2017 Status changed from active, no longer recruiting to discontinued.
- 28 Apr 2017 Planned End Date changed from 1 Aug 2018 to 1 Aug 2017.